- Home
- / Yifan Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Yifan Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥12
2024-10-29
Market Capitalization
¥14.4 B
2024-10-29
Revenue
¥5.1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.6B | 5.1B | 5.3B | 4.3B | 3.8B | 4.0B | 5.1B | 5.1B |
| Cost of goods sold | 2.6B | 2.8B | 2.9B | 2.6B | 2.0B | 2.1B | 2.7B | 2.7B |
| Gross profit | 2.0B | 2.4B | 2.5B | 1.8B | 1.8B | 1.9B | 2.4B | 2.4B |
| Gross profit margin, % | 46.0% | 46.3% | 41.3% | 47.5% | 47.1% | 46.6% | ||
| Operating expense total | 804.2M | 1.1B | 1.3B | 1.3B | 1.5B | 1.5B | 1.6B | 1.5B |
| Depreciation and amortization | 291.1M | 230.8M | 179.2M | 212.0M | 236.4M | 1.1B | 339.4M | 358.4M |
| EBITDA | 1.2B | 1.2B | 1.2B | 476.0M | 346.2M | 359.2M | 741.8M | 818.4M |
| EBITDA margin, % | 24.4% | 22.7% | 11.0% | 9.0% | 14.6% | 16.2% | ||
| EBIT | 900.1M | 1.1B | 1.1B | 287.5M | 197.1M | (795.1M) | 476.5M | 503.2M |
| EBIT margin, % | 21.1% | 21.4% | 6.6% | -19.9% | 9.4% | 10.0% | ||
| Interest income | 46.7M | 20.7M | 26.3M | 25.3M | 21.4M | 13.1M | 8.1M | 12.1M |
| Interest expense | 61.8M | 70.4M | 71.1M | 74.6M | 85.8M | 75.6M | 69.1M | 53.0M |
| Pre tax profit | 884.9M | 1.1B | 1.1B | 210.8M | 156.7M | (869.0M) | 388.7M | 423.7M |
| Income tax expense | 191.2M | 195.1M | 149.3M | (31.4M) | 29.6M | 16.6M | 65.0M | 50.3M |
| Net Income | 693.7M | 873.1M | 931.4M | 242.2M | 127.2M | (885.6M) | 323.6M | 373.5M |